PIA
RGNX icon

Piedmont Investment Advisors’s Regenxbio RGNX Stock Holding History

Piedmont Investment Advisors’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-7,716
Closed -$442K – 1193
2019
Q1 		$442K Buy
7,716
+518
+7% +$25.7K 0.02% 589
2018
Q4 		$302K Buy
7,198
+395
+6% +$23.2K 0.01% 720
2018
Q3 		$514K Buy
6,803
+522
+8% +$37.6K 0.02% 504
2018
Q2 		$451K Buy
+6,281
New +$300K 0.02% 477

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
WM
WS Management Jacksonville, Florida $1.13B AUM 53.44% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Piedmont Investment Advisors's RGNX Position: Q2 2019 in Review

Piedmont Investment Advisors sold out of Regenxbio (RGNX) in Q2 2019, closing a stake of 7,716 shares — an estimated $442K sold.

Piedmont Investment Advisors first reported a position in RGNX in Q2 2018 and held it in 4 quarters. The position peaked at $514K in Q3 2018. 186 funds tracked by Wall St. Rank hold RGNX as of Q2 2019.

  • Piedmont Investment Advisors reported no remaining Regenxbio position as of Q2 2019 after selling out during the quarter.
  • Piedmont Investment Advisors sold 7,716 Regenxbio shares in Q2 2019, an estimated $442K.
  • Piedmont Investment Advisors first reported a position in Regenxbio in Q2 2018 and held it in 4 quarters.
  • Piedmont Investment Advisors's Regenxbio position peaked at $514K in Q3 2018.
  • 186 funds tracked by Wall St. Rank held Regenxbio as of Q2 2019.

Based on Piedmont Investment Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.